Another endogenous matricellular inhibitor of angiogenesis is TSP-1, a calcium-binding glycoprotein belonging to the thrombospondin family that exerts its anti-tumorigenic activity on both tumor and endothelial cells (128, 129), reducing VEGF expression (130, 131) and disrupting VEGF signaling (132). Here, VEGFA is linked to neoplasm.